Jian Ding
suozhang@mail.shcnc.ac.cn
Chinese, Japanese
Shanghai
University of Chinese Academy of Sciences
Medical School
  • 1986-10--1991-10 Ph.D.: Kyushu University, Japan
  • 1980-09--1983-08 Master's: China Medical University
  • 1975-11--1978-09 Studied at Jiangxi Medical College
  • 2005-01--2012-01 Director/Researcher: State Key Laboratory of New Drug Research
  • 2001-01--2003-01 Director/Researcher: National Center for New Drug Screening
  • 1996-08--2004-11 Deputy Director/Researcher: Shanghai Institute of Materia Medica, Chinese Academy of Sciences
  • 1994-02--Present Group Leader/Researcher: Shanghai Institute of Materia Medica, Chinese Academy of Sciences
  • 1992-02--1994-02 Postdoctoral: Shanghai Institute of Materia Medica, Chinese Academy of Sciences
  • 1991-11--1992-01 Visiting Scholar: Kyushu University, Japan
  • 1978-10--1986-09 Teacher: Jiangxi Medical College
  • 1969-09--1975-09 Educated Youth: Chongren County, Jiangxi Province
  • National Natural Science Award, Second Prize, National Level, 2013
  • Shanghai Natural Science First Prize, Provincial Level, 2010
  • National Natural Science Award, Second Prize, National Level, 2009
  • Shanghai Natural Science First Prize, Provincial Level, 2007
Pharmacology of Anticancer Drugs
Molecular Pharmacology
  • Intact regulation of G1/S transition renders esophageal squamous cell carcinoma sensitive to PI3Kα inhibitors, Xu Zhang, Yuxiang Wang, Xi Zhang, Yanyan Shen, Kang Yang, Qingyang Ma, Yuemei Qiao, Jiajie Shi, Yi Wang, Lan Xu, Biyu Yang, Gaoxiang Ge, Landian Hu, Xiangyin Kong, Chunhao Yang, Yi Chen, Jian Ding, Linghua Meng, 2023
  • Histone deacetylase inhibitors promote breast cancer metastasis by elevating NEDD9 expression, Zonglong Hu, Fan Wei, Yi Su, Yafang Wang, Yanyan Shen, Yanfen Fang, Jian Ding, Yi Chen, 2023
  • LS-106, a novel EGFR inhibitor targeting C797S, exhibits antitumor activities both in vitro and in vivo, Liu, Yingqiang, Lai, Mengzhen, Li, Shan, Wang, Yanan, Feng, Fang, Zhang, Tao, Tong, Linjiang, Zhang, Mengge, Chen, Hao, Chen, Yi, Song, Peiran, Li, Yan, Bai, Gang, Ning, Yi, Tang, Haotian, Fang, Yan, Chen, Yi, Lu, Xiaoyun, Geng, Meiyu, Ding, Ke, Yu, Ker, Xie, Hua, Ding, Jian, 2022
  • A Novel SphK1 Inhibitor Suppresses Growth of Solid Tumor and Inhibits the Lung Metastasis of Triple-negative Breast Cancer, Zhang, Shurui, Chen, Xiaoxu, Wu, Chenglin, Xu, Hui, Xie, Xiong, Feng, Mingshun, Hu, Shulei, Hudagula Bai, Gao, Feng, Tong, Linjiang, Ding, Jian, Liu, Hong, Xie, Zuoquan, Wang, Jiang, 2022
  • ASK120067 potently suppresses B-cell or T-cell malignancies in vitro and in vivo by inhibiting BTK and ITK, Song, Peiran, Bai, Gang, Chan, Shingpan, Zhang, Tao, Tong, Linjiang, Su, Yi, Shen, Yanyan, Chen, Yi, Liu, Yingqiang, Lai, Mengzhen, Ning, Yi, Tang, Haotian, Fang, Yan, Chen, Yi, Ding, Ke, Ding, Jian, Xie, Hua, 2022
Cancer Pharmacology Drug Development Molecular Biology Chemotherapy Targeted Therapy Signal Transduction Cell Biology Clinical Trials Biochemistry

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.